Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab

被引:2
|
作者
Garceau, Patrick [1 ]
Couture, Christian [1 ]
Cantin, Bernard [1 ]
Bernier, Vincent [2 ]
Senechal, Mario [1 ]
机构
[1] Hop Laval, Inst Cardiol Quebec, Dept Cardiol, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Quebec, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada
来源
关键词
D O I
10.1016/j.healun.2008.05.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Post-transplant lymphoproliferative disorder (PTLD) is often associated with Epstein-Barr virus (EBV). However, in this report, we describe a heart transplant recipient with pathologically proven EBV-positive PTLD with undetectable virus by polymerase chain reaction. The patient had remission after anti-CD20 antibody treatment early after transplantation.
引用
收藏
页码:928 / 931
页数:4
相关论文
共 50 条
  • [21] Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a renal transplant recipient treated with tacrolimus and antithymocyte globulin
    Chan, ALF
    Wang, HY
    CLINICAL DRUG INVESTIGATION, 2003, 23 (04) : 281 - 283
  • [22] Epstein-Barr virus, post-transplant lymphoproliferative disease and animal models
    Johannessen, I
    REVIEWS IN MEDICAL MICROBIOLOGY, 2002, 13 (03) : 129 - 140
  • [23] Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders
    Martin Rowe
    Gerald Niedobitek
    Lawrence S. Young
    Springer Seminars in Immunopathology, 1998, 20 : 389 - 403
  • [24] Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders
    Rowe, M
    Niedobitek, G
    Young, LS
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (3-4): : 389 - 403
  • [25] A Post-transplant Immunosuppression Complication: Epstein-Barr Virus-Positive Classic Hodgkin Lymphoma Post-transplant Lymphoproliferative Disorder
    Zaver, Himesh B.
    Prakash, Gautham
    Plant, Samuel
    Chaudhari, Jigisha
    Erno, Jason
    Mithqal, Ayman
    Courville, Elizabeth
    Marchi, Enrica
    Henry, Zachary
    ACG CASE REPORTS JOURNAL, 2025, 12 (02)
  • [26] Epstein-Barr Virus Recipient and Donor Serostatus, Post-Transplant Lymphoproliferative Disorder and Outcomes in Kidney Transplant Recipients
    Sampaio, M. S.
    Shah, T.
    Hutchinson, I. V.
    Cho, Y. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 104 - 104
  • [27] Epstein-Barr virus-associated post-transplant lymphoproliferative disorder of plasma cell type following allogeneic haemopoietic stem cell transplant treated with rituximab
    Getta, B.
    Kwan, J.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (08) : 821 - 821
  • [28] Fatal Case of Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Disorder With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient
    de Figueiredo, Sergio Mazzola Poli
    Hussain, Syed A.
    Johnson, John C.
    Mujtaba, Muhammad A.
    Kulkarni, Rupak
    Lyapichev, Kirill A.
    Lea, Alfred S.
    Kueht, Michael
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 977 - 977
  • [29] Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder
    Holman, Carol J.
    Karger, Amy B.
    Mullan, Beth D.
    Brundage, Richard C.
    Balfour, Henry H., Jr.
    CLINICAL TRANSPLANTATION, 2012, 26 (05) : 741 - 747
  • [30] EPSTEIN-BARR VIRUS (EBV), IMMUNOGLOBULIN, AND MYC GENES IN THE POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)
    LOCKER, J
    NALESNIK, M
    FASEB JOURNAL, 1988, 2 (05): : A1158 - A1158